McKesson Corporation (MCK) Shares Bought by Vanguard Group Inc.
Vanguard Group Inc. grew its holdings in shares of McKesson Corporation (NYSE:MCK) by 0.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,090,544 shares of the company’s stock after buying an additional 62,004 shares during the quarter. Vanguard Group Inc. owned 6.70% of McKesson Corporation worth $2,318,457,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Wells Fargo & Company MN boosted its stake in shares of McKesson Corporation by 12.7% during the 2nd quarter. Wells Fargo & Company MN now owns 2,121,171 shares of the company’s stock valued at $349,017,000 after buying an additional 239,358 shares during the last quarter. Loews Corp purchased a new position in shares of McKesson Corporation during the 1st quarter valued at approximately $253,000. Pictet & Cie Europe SA boosted its stake in shares of McKesson Corporation by 30.0% during the 2nd quarter. Pictet & Cie Europe SA now owns 6,542 shares of the company’s stock valued at $1,076,000 after buying an additional 1,510 shares during the last quarter. HealthInvest Partners AB boosted its stake in shares of McKesson Corporation by 23.7% during the 2nd quarter. HealthInvest Partners AB now owns 63,100 shares of the company’s stock valued at $10,382,000 after buying an additional 12,100 shares during the last quarter. Finally, Dai Ichi Life Insurance Company Ltd boosted its stake in shares of McKesson Corporation by 194.3% during the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 29,462 shares of the company’s stock valued at $4,848,000 after buying an additional 19,450 shares during the last quarter. Institutional investors own 85.16% of the company’s stock.
Shares of McKesson Corporation (NYSE:MCK) traded up 0.97% on Thursday, reaching $151.63. The company had a trading volume of 244,181 shares. The firm has a market cap of $31.88 billion, a P/E ratio of 6.88 and a beta of 1.16. McKesson Corporation has a one year low of $114.53 and a one year high of $169.29. The company has a 50-day moving average price of $151.41 and a 200-day moving average price of $153.02.
McKesson Corporation (NYSE:MCK) last released its earnings results on Thursday, July 27th. The company reported $2.46 earnings per share for the quarter, missing analysts’ consensus estimates of $2.81 by ($0.35). The firm had revenue of $51.05 billion for the quarter, compared to the consensus estimate of $51.22 billion. McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.50 EPS. On average, analysts expect that McKesson Corporation will post $12.08 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Stockholders of record on Friday, September 1st will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Wednesday, August 30th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.91%. This is an increase from McKesson Corporation’s previous quarterly dividend of $0.28. McKesson Corporation’s payout ratio is presently 6.07%.
TRADEMARK VIOLATION NOTICE: “McKesson Corporation (MCK) Shares Bought by Vanguard Group Inc.” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/09/21/mckesson-corporation-mck-shares-bought-by-vanguard-group-inc.html.
In related news, Director M Christine Jacobs sold 1,083 shares of the company’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $145.43, for a total value of $157,500.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Erin M. Lampert sold 900 shares of the company’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $155.65, for a total value of $140,085.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 3,066 shares of company stock valued at $473,627. 1.20% of the stock is currently owned by corporate insiders.
Several equities research analysts recently issued reports on MCK shares. BidaskClub lowered McKesson Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Zacks Investment Research raised McKesson Corporation from a “hold” rating to a “buy” rating and set a $184.00 price target on the stock in a research report on Wednesday, July 12th. Robert W. Baird raised McKesson Corporation from a “neutral” rating to an “outperform” rating and upped their price target for the company from $175.00 to $178.00 in a research report on Tuesday. Vetr raised McKesson Corporation from a “hold” rating to a “buy” rating and set a $174.15 price target on the stock in a research report on Thursday, May 25th. Finally, TheStreet lowered McKesson Corporation from a “b” rating to a “c+” rating in a research report on Friday, August 25th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the company. McKesson Corporation currently has an average rating of “Hold” and a consensus target price of $171.53.
McKesson Corporation Profile
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
Receive News & Stock Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related stocks with our FREE daily email newsletter.